Europe must act now to strengthen maternal vaccination during pregnancy and ensure all women and babies can benefit from a new generation of vaccines to protect against serious infections. That is according to a new Lancet Regional Health - Europe series led by Professor Asma Khalil at City St George's, University of London, which is being launched and presented at the 2026 Global Society for Maternal-Fetal Medicine Congress in Utrecht.
Strengthening Maternal Vaccination in Europe: A Call to Action for Women's Health
A new Lancet Regional Health - Europe series emphasizes the need for improved maternal vaccination in Europe to protect women and infants from serious infections. Led by Professor Asma Khalil, the findings will be presented at the 2026 Global Society for Maternal-Fetal Medicine Congress. This issue of unequal access to vaccines could also resonate with Iran, highlighting similar challenges in maternal health.
👥 Key Players
📰 What Happened
A new series published in Lancet Regional Health - Europe calls for enhanced maternal vaccination in Europe to protect women and infants from serious infections. The findings will be presented at an upcoming medical congress in 2026.
- The series emphasizes the importance of maternal vaccination during pregnancy.
- The findings highlight existing inequalities in vaccine access that could affect maternal health.
💡 Why It Matters
📚 Background
Maternal vaccination is crucial for protecting both mothers and infants from infectious diseases, and disparities in access to these vaccines can lead to higher health risks.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%